Back

Association between brain natriuretic peptide levels and left ventricular ejection fraction in patients with preserved left ventricular ejection fraction.

28 August 2016 (10:33 - 10:40)
Organised by:
Congress Presentation Part of: New targets for biomarkers in heart failure Diastolic dysfunction ESC Premium Access ESC Congress 2016

About the speaker

Photo
Assistant Professor Shuichi Kitada

Nagoya City University Graduate School of Medical Sciences, Nagoya (Japan)

6 More presentations in this session

Presentation thumbnail
NEOD001 demonstrates cardiac biomarker responses in patients with light chain amyloidosis and persistent organ dysfunction: results from the expansion phase of a phase 1/2 study
Assistant Professor M. Liedtke (Stanford, US)
Abstract
Presentation thumbnail
Changes in BNP prior to major cardiovascular events in patients with type 2 diabetes and a recent coronary event
Doctor E. Wolsk (Herlev, DK)
Abstract Slides
Presentation thumbnail
Novel biomarkers in heart failure with reduced and preserved ejection fraction in the general population
Doctor C. Sinning (Hamburg, DE)
Abstract Slides
Presentation thumbnail
Increased levels of urinary biomarkers of tubular injury as a predictor of poor diuretic response in acute heart failure
Doctor M. Sokolski (Wroclaw, PL)
Abstract Slides
Presentation thumbnail
The combination of collagen type I-related biomarkers identifies a malignant phenotype of myocardial fibrosis in hypertensive heart failure
Associate Professor A. Gonzalez Miqueo (Pamplona, ES)
Abstract

Access the full session

Session thumbnail
New targets for biomarkers in heart failure

The Event

Event poster

ESC Congress 2016

28 August 2016 10:33 CET
You may be interested in
thumbnail
Congress Presentation
Low natriuretic peptide levels in heart failure with preserved ejection fraction
29 June 2021
thumbnail
Congress Session
From genetic signatures to clinical implications
18 May 2025
thumbnail
Congress Presentation
Imaging research in Circulation
31 August 2025
thumbnail
Congress Presentation
Approaches to developing a standardized screening and intervention strategy in patients with coronary artery disease and type 2 diabetes mellitus at risk of heart failure
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources